HCPCS drug code · CMS crosswalk
Albuterol Sulfate J-Code / HCPCS Code
In short
CMS assigns Albuterol Sulfate NDCs to 2 HCPCS codes: J7611 (per 1 mg), J7613 (per 1 mg). Which one applies depends on the product; the table lists each NDC with its code.
Reference
- J7611
- Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mgBilling unit: 1 mg
- J7613
- Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mgBilling unit: 1 mg
- Labelers
- A-S Medication Solutions; Actavis Pharma, Inc.; American Health Packaging; Chartwell; Ingenus Pharmaceuticals LLC; Mylan Pharmaceuticals Inc.; Nephron SC, Inc.; Rising Pharma Holdings, Inc.and 2 more
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Albuterol Sulfate units and claim line
Enter the dose given to get the J7611 units and the NDC line for the CMS-1500 and the 837P. This builds the J7611 line; use the code page for J7613.
Enter the dose given to build the claim line.
Albuterol Sulfate NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 00487-9901-30 | J7611 | Nephron SC, Inc. | 30 × 0.5 | 75 |
| 62135-0829-84 | J7611 | Chartwell | 30 × 0.5 | 75 |
| 64980-0642-03 | J7611 | Rising Pharma Holdings, Inc. | 30 × 0.5 | 75 |
| 76204-0027-01 | J7611 | Ritedose Pharmaceuticals, LLC | 30 × 0.5 | 75 |
| 00378-7057-52 | J7613 | Mylan Pharmaceuticals Inc. | 25 × 3 | 16 |
| 00378-7058-52 | J7613 | Mylan Pharmaceuticals Inc. | 25 × 3 | 32 |
| 00378-8270-52 | J7613 | Mylan Pharmaceuticals Inc. | 25 × 3 | 63 |
| 00378-8270-55 | J7613 | Mylan Pharmaceuticals Inc. | 30 × 3 | 75 |
| 00378-8270-91 | J7613 | Mylan Pharmaceuticals Inc. | 60 × 3 | 150 |
| 00378-8270-93 | J7613 | Mylan Pharmaceuticals Inc. | 30 × 3 | 75 |
| 00487-0301-01 | J7613 | Nephron SC, Inc. | 30 × 3 | 19 |
| 00487-9501-01 | J7613 | Nephron SC, Inc. | 30 × 3 | 75 |
| 00487-9501-03 | J7613 | Nephron SC, Inc. | 30 × 3 | 75 |
| 00487-9501-25 | J7613 | Nephron SC, Inc. | 25 × 3 | 63 |
| 00487-9501-60 | J7613 | Nephron SC, Inc. | 60 × 3 | 150 |
| 00487-9904-01 | J7613 | Nephron SC, Inc. | 30 × 3 | 38 |
| 00487-9904-25 | J7613 | Nephron SC, Inc. | 25 × 3 | 32 |
| 00591-3467-53 | J7613 | Actavis Pharma, Inc. | 25 × 3 | 16 |
| 00591-3468-53 | J7613 | Actavis Pharma, Inc. | 25 × 3 | 32 |
| 47335-0703-49 | J7613 | Sun Pharmaceutical Global FZE. | 25 × 3 | 63 |
| 47335-0703-52 | J7613 | Sun Pharmaceutical Global FZE. | 30 × 3 | 75 |
| 47335-0703-54 | J7613 | Sun Pharmaceutical Global FZE. | 60 × 3 | 150 |
| 50090-0516-00 | J7613 | A-S Medication Solutions | 25 × 3 | 63 |
| 50090-0516-01 | J7613 | A-S Medication Solutions | 125 × 3 | 313 |
| 50090-6560-00 | J7613 | A-S Medication Solutions | 25 × 3 | 63 |
| 50090-6560-01 | J7613 | A-S Medication Solutions | 75 × 3 | 188 |
| 50742-0392-25 | J7613 | Ingenus Pharmaceuticals LLC | 25 × 3 | 16 |
| 50742-0393-25 | J7613 | Ingenus Pharmaceuticals LLC | 25 × 3 | 32 |
| 60687-0395-83 | J7613 | American Health Packaging | 30 × 3 | 75 |
| 62135-0826-84 | J7613 | Chartwell | 30 × 3 | 19 |
| 62135-0827-84 | J7613 | Chartwell | 30 × 3 | 38 |
| 62135-0828-84 | J7613 | Chartwell | 30 × 3 | 75 |
| 76204-0010-01 | J7613 | Ritedose Pharmaceuticals, LLC | 30 × 3 | 19 |
| 76204-0010-55 | J7613 | Ritedose Pharmaceuticals, LLC | 25 × 3 | 16 |
| 76204-0011-01 | J7613 | Ritedose Pharmaceuticals, LLC | 30 × 3 | 38 |
| 76204-0011-55 | J7613 | Ritedose Pharmaceuticals, LLC | 25 × 3 | 32 |
| 76204-0200-01 | J7613 | Ritedose Pharmaceuticals, LLC | 30 × 3 | 75 |
| 76204-0200-25 | J7613 | Ritedose Pharmaceuticals, LLC | 25 × 3 | 63 |
| 76204-0200-30 | J7613 | Ritedose Pharmaceuticals, LLC | 30 × 3 | 75 |
| 76204-0200-60 | J7613 | Ritedose Pharmaceuticals, LLC | 60 × 3 | 150 |
Albuterol Sulfate: common questions
- What is the J-code for Albuterol Sulfate?
- CMS assigns Albuterol Sulfate NDCs to 2 HCPCS codes: J7611 (per 1 mg), J7613 (per 1 mg). Which one applies depends on the product; the table lists each NDC with its code.
- How many J7611 billing units are in a package of Albuterol Sulfate?
- CMS lists 75 billing units per package, depending on the NDC, where one unit is 1 mg. Units to report are based on the dose given, not the package.
- How many J7613 billing units are in a package of Albuterol Sulfate?
- CMS lists 16 to 313 billing units per package, depending on the NDC, where one unit is 1 mg. Units to report are based on the dose given, not the package.
- Is J7611 a CPT code?
- No. J7611 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.
Other codes for the same drug
- J7609Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
- J7610Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
- J7620Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme